BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29506502)

  • 21. Comparison of immunity against canine distemper, adenovirus and parvovirus after vaccination with two multivalent canine vaccines.
    Cunha RDS; da Silva Junior CL; Costa CA; de Aguiar HM; Junqueira Júnior DG
    Vet Med Sci; 2020 Aug; 6(3):330-334. PubMed ID: 32338828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological responses of adult dogs to revaccination against distemper, parvovirus and rabies.
    Ottiger HP; Neimeier-Förster M; Stärk KD; Duchow K; Bruckner L
    Vet Rec; 2006 Jul; 159(1):7-12. PubMed ID: 16816154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic response of maned wolves (Chrysocyon brachyurus) to canine and canine parvovirus vaccination distemper virus.
    Maia OB; Gouveia AM
    J Zoo Wildl Med; 2001 Mar; 32(1):78-80. PubMed ID: 12790399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposing views of revaccination strategies.
    Palmquist R
    J Am Vet Med Assoc; 2000 Dec; 217(12):1789-91. PubMed ID: 11132877
    [No Abstract]   [Full Text] [Related]  

  • 25. Duration of immunity in red wolves (Canis rufus) following vaccination with a modified live parvovirus and canine distemper vaccine.
    Anderson K; Case A; Woodie K; Waddell W; Reed HH
    J Zoo Wildl Med; 2014 Sep; 45(3):550-4. PubMed ID: 25314821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
    Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
    J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canine viral vaccines at a turning point--a personal perspective.
    Carmichael LE
    Adv Vet Med; 1999; 41():289-307. PubMed ID: 9890023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of age and vaccination interval on canine parvovirus, distemper virus, and adenovirus serum antibody titers.
    Gonzalez SE; Gogal RM; Meindl AG; Boyer N; Nelson S; Everett SE; Vetter CA; Gonzalez JM
    Vet Immunol Immunopathol; 2023 Aug; 262():110630. PubMed ID: 37418822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a dot ELISA kit for measuring immunoglobulin M antibodies to canine parvovirus and distemper virus.
    Waner T; Mazar S; Nachmias E; Keren-Kornblatt E; Harrus S
    Vet Rec; 2003 May; 152(19):588-91. PubMed ID: 12762487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a Community's Risk for Canine Parvovirus and Distemper Using Antibody Testing and GIS Mapping of Animal Shelter Intakes.
    Spindel ME; Krecic MR; Slater MR; Vigil N
    J Appl Anim Welf Sci; 2018; 21(4):362-374. PubMed ID: 29557180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine parvovirus infection, canine distemper and infectious canine hepatitis: inclination to vaccinate and antibody response in the Swedish dog population.
    Olson P; Hedhammar A; Klingeborn B
    Acta Vet Scand; 1996; 37(4):433-43. PubMed ID: 9050276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.
    Böhm M; Thompson H; Weir A; Hasted AM; Maxwell NS; Herrtage ME
    Vet Rec; 2004 Apr; 154(15):457-63. PubMed ID: 15119729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
    Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
    Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of serum antibody titers against canine distemper virus and canine parvovirus in dogs hospitalized in an intensive care unit.
    Mahon JL; Rozanski EA; Paul AL
    J Am Vet Med Assoc; 2017 Jun; 250(12):1413-1418. PubMed ID: 28569640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of protective antibody titers for canine distemper virus and canine parvovirus in dogs entering a Florida animal shelter.
    Lechner ES; Crawford PC; Levy JK; Edinboro CH; Dubovi EJ; Caligiuri R
    J Am Vet Med Assoc; 2010 Jun; 236(12):1317-21. PubMed ID: 20550446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of body weight on antibody titers against canine parvovirus type 2, canine distemper virus, and canine adenovirus type 1 in vaccinated domestic adult dogs.
    Taguchi M; Namikawa K; Maruo T; Saito M; Lynch J; Sahara H
    Can J Vet Res; 2012 Oct; 76(4):317-9. PubMed ID: 23543958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.